《經濟數據》美國2月裏奇蒙製造業指數續降至1
美國裏奇蒙聯儲(Richmond Fed)調查顯示,經季節調整後,美國2022年2月裏奇蒙製造業指數連續兩個月急降,由前值8,續降至1,反映美國第五區製造業活動進一步放緩至接近停滯。
期內,新訂單連續兩個月急降兼重陷收縮,由前值6,續降至負3;出貨指數終止連月上升兼重陷收縮,由前值14,急降至負11;訂單積壓指數由歷來第二高(26)連降第二個月至負4(前值2),爲2020年6月以來首呈負值;供貨時間由前值50,回落至45;但就業終止連月急降,由前值4,急彈至20,收復前值急降所有失地有餘。然而,由於預期指數仍處於負值區域,公司預計這一挑戰將至少持續六個月。
上述指標以「零」爲擴張及收縮分嶺線。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.